Suppr超能文献

肺动脉高压相关的死亡率的阈值。

Threshold of Pulmonary Hypertension Associated With Increased Mortality.

机构信息

University of Notre Dame, Fremantle, Western Australia, Australia.

University of Cape Town, Cape Town, South Africa.

出版信息

J Am Coll Cardiol. 2019 Jun 4;73(21):2660-2672. doi: 10.1016/j.jacc.2019.03.482.

Abstract

BACKGROUND

There is increasing evidence that current thresholds for diagnosing pulmonary hypertension (PHT) underestimate the prognostic impact of PHT.

OBJECTIVES

The aim of this study was to determine the prognostic impact of increasing pulmonary pressures within the National Echocardiography Database of Australia cohort (n = 313,492).

METHODS

The distribution of estimated right ventricular systolic pressure (eRVSP) was examined in 157,842 men and women. All had data linkage to long-term survival during median follow-up of 4.2 years (interquartile range: 2.2 to 7.5 years).

RESULTS

The cohort comprised 74,405 men and 83,437 women 65.6 ± 17.7 years of age. Overall, 17,955 (11.4%), 7,016 (4.4%), and 4,515 (2.9%) subjects had eRVSP levels indicative of mild (40 to 49 mm Hg), moderate (50 to 59 mm Hg), or severe (≥60 mm Hg) PHT, respectively, assuming a right atrial pressure of 5 mm Hg. These subjects were more likely to die during long-term follow up (for severe PHT, adjusted hazard ratio: 9.73; 95% confidence interval: 8.60 to 11.0; p < 0.001). After adjustment for age, sex, and evidence of left heart disease, those subjects with eRVSP levels within the third (28.05 to 32.0 mm Hg; hazard ratio: 1.410; 95% confidence interval: 1.310 to 1.517) and fourth (32.05 to 38.83 mm Hg; hazard ratio: 1.979; 95% confidence interval: 1.853 to 2.114) quintiles had significantly higher mortality (p < 0.001) than those in the lowest quintile. Accordingly, a clear and consistent threshold of increased mortality (including 1- and 5-year actuarial mortality) around an eRVSP of 30.0 mm Hg was evident.

CONCLUSIONS

In this large and unique cohort, the prognostic impact of clinically accepted levels of PHT was confirmed. Moreover, a distinctly lower threshold for increased risk for mortality (eRVSP >30.0 mm Hg) indicative of PHT was identified. (A Longitudinal Cohort Study of Echocardiograms From Public and Private Echocardiography Laboratories From Around Australia, Linked With the National Deaths Index; ACTRN12617001387314).

摘要

背景

越来越多的证据表明,目前诊断肺动脉高压(PHT)的阈值低估了 PHT 的预后影响。

目的

本研究旨在确定澳大利亚国家超声心动图数据库队列(n=313492)中肺动脉压力升高的预后影响。

方法

在 157842 名男性和女性中检查了估计右心室收缩压(eRVSP)的分布。所有患者均在中位随访 4.2 年(四分位距:2.2 至 7.5 年)期间的数据链接到长期生存。

结果

该队列包括 74405 名男性和 83437 名女性,年龄为 65.6±17.7 岁。总体而言,17955(11.4%)、7016(4.4%)和 4515(2.9%)名患者的 eRVSP 水平分别为轻度(40 至 49mmHg)、中度(50 至 59mmHg)和重度(≥60mmHg)PHT,假设右心房压力为 5mmHg。这些患者在长期随访中更有可能死亡(严重 PHT 时,调整后的危险比:9.73;95%置信区间:8.60 至 11.0;p<0.001)。在调整年龄、性别和左心疾病证据后,那些 eRVSP 水平处于第三(28.05 至 32.0mmHg;危险比:1.410;95%置信区间:1.310 至 1.517)和第四(32.05 至 38.83mmHg;危险比:1.979;95%置信区间:1.853 至 2.114)五分位的患者死亡率显著更高(p<0.001)比那些处于最低五分位的患者。因此,明显且一致的死亡率增加阈值(包括 1 年和 5 年实际死亡率)约为 30.0mmHg 的 eRVSP 是显而易见的。

结论

在这项大型且独特的队列研究中,证实了临床接受的 PHT 水平的预后影响。此外,确定了死亡率风险增加的明显较低阈值(eRVSP>30.0mmHg),表明存在 PHT。(一项来自澳大利亚公共和私人超声心动图实验室的超声心动图的纵向队列研究,与国家死亡索引相关联;ACTRN12617001387314)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验